Langerhans cellhistiocytos
Senast uppdaterad: Publicerad:
Sakkunnig:Honar Cherif- McClain KL. Drug therapy for the treatment of Langerhans cell histiocytosis. Expert Opin Pharmacother 2005; 6: 2435-41. PubMed
- Writing group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987; 1: 208-09.
- Leonidas JC, Guelfguat M, Valderrama E. Langerhans' cell histiocytosis. Lancet 2003; 361: 1293-5. PubMed
- Malpas JS, Norton AJ. Langerhans Cell Histiocytosis in the Adult. Med Ped Oncol 1996; 27: 540-6. PubMed
- Selim MA, Shea CR. Langerhans cell histiocytosis. eMedicine 2002; February 27: www.emedicine.com.
- Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans Cell Histiocytosis in Adults. Med Ped Oncol 1997; 28: 9-14. PubMed
- Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmondson JH, Schomberg PJ. Langerhans Cell Histiocytosis: Diagnosis, Natural History, Management and Outcome. Cancer 1999; 85: 2278-90. PubMed
- de Graaf JH, Egeler RM. New insights into the pathogenesis of Langerhans cell histiocytosis. Curr Opin Pediatr 1997; 9: 46-50. PubMed
- Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocotosis X) - a clonal proliferative disease . N Engl J Med 1994; 331: 154. PubMed
- Kaltsas GA, Powles TB, Evanson J, et al. Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000; 85: 1370-6. PubMed
- Coury F, Annels N, Rivollier A, et al. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nature Medicine 2008; 14: 81-7. PubMed
- Coppes-Zantinga A, Egeler RM. The Langerhans Cell Histiocytosis X files revealed. Br J Haematol 2002; 116: 3-9. PubMed
- Saven A, Burian C. Cladribrine activity in adult Langerhans-cell histiocytosis. Blood 1999; 93: 4125-30. PubMed
- Dunger DB, Broadbent V, Yeoman E, et al. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. N Engl J Med 1989; 321: 1157-62. PubMed
- Egeler RM, D'Angio GJ. Langerhans Cell Histiocytosis. J Pediatr 1992; 127: 1-11. PubMed
- Egeler RM. LCH: The symptoms, diagnosis and treatment. Histiocyte Society 2003; July: www.histio.org/society.
- Maghnie M, Cosi G, Genovese E, et. al. Central Diabetes Insipidus in Children and Young Adults. N Engl J Med 2000; 343: 998-1007. New England Journal of Medicine
- Travis WD, Borok Z, Roum JH, Zhang J, Feuerstein I, Ferrans VJ, Crystal RG. Pulmonary Langerhans Cell Granulomatosis (Histiocytosis X): A Clinicopathologic Study of 48 Cases. Am J Surg Pathol 1993; 17: 971-86. PubMed
- Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 287-305 PubMed
- Modan-Moses D, Weintraub M, Meyerovitch J, Segal-Lieberman G, Bielora B. Hypopituitarism in langerhans cell histiocytosis: seven cases and a literature review. J Endocrinol Invest 2001; 24: 612-7. PubMed
- Delobbe A, Durieu J, Duhamel A, Walleert B. Determinants of Survival in Pulmonary Langerhans Cell Granulomatosis (Histiocytosis X). Eur Respir J 1996; 9: 2002-6. PubMed
- Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE. Pulmonary Histiocytosis X: Pulmonary Function and Exercise Pathophysiology. Am J Respir Crit Care Med 1996; 153: 426-35. PubMed
- Büchler T, Cervinek L, Belohlavek O, et al. Langerhans cell histiocytosis with central nervous system involvement: Follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 2004; 43: 1-3. PubMed
- Egeler RM, de Kraker J, Voute PA: Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: Experience at a single institution. Med Pediatr Oncol 1993; 21: 265. PubMed
- Viana MB, Oliverira BM, Silva CM, Rios Leite VH: Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X). Med Pediatr Oncol 1991; 19: 289. PubMed
- Saven A, Foon KA, Piro LD. 2-Chlorodeoxyadenosine-induced Complete Remissions in Langerhans Cell Histiocytosis. Ann Int Med 1994; 121: 430-2. PubMed
- Weitzman S, Wayn AS, Arceci R, Lipton JM, Whitlock JA, De Rossi G. Nucleoside Analogues in the Therapy of Langerhans Cell Histiocytosis: A Survey of Members of the Histiocyte Society and Review of the Literature. Med Ped Oncol 1999; 33; 476-81.
- Jordan MB, McClain KL, Yan X, Hicks J, Jaffe R. Langerhans cells in Langerhans cell histocytosis express CD52 (Campath). Pediatr Blood Cancer 2005; 44: 251-5. PubMed
- von Stebut E, Schadmand-Fischer S, Bräuninger W, Kreft A, Doberauer C, Steinbrink K. Successful treatment of adult multisystemic Langerhans cell histiocytosis with Psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine. Arch Dermatol 2008; 144: 649-53. PubMed
- Vourtsi A, Papadopoulos A, Moulopoulos LA, Xenellis J, Vlahos L. Langerhans cell histiocytosis with involvement of the pons: case report. Neuroradiology 1998; 40: 161-3. PubMed
- Hund E, Steiner H, Jansen O, Sieverts H, Sohl G, Essig M. Treatment of cerebral Langerhans cell histiocytosis. J Neurol Sci 1999; 171: 145-52. PubMed
- Nagarajan R, Neglia J, Ramsay N, Baker KS. Successful treatment of Langerhans cell histiocytosis with unrelated cord blood transplantation. J Pediatr Hematol Oncol 2001; 23: 632-39. PubMed
- Conter V, Reciputo A, Arrigo C, Bozzato N, Sala A, Arico C. Bone marrow transplantation for refractory Langerhans cell hystiocytosis. Haematologica 1996; 81: 468-71. PubMed
- Grundy P, Ellis R: Histiocytosis X: A review of the etiology, pathology, staging, and therapy. Med Pediatr Oncol 1986; 14: 45. PubMed
- Komp DM: Concepts in staging and clinical studies for treatment of Langerhans' cell histiocytosis. Semin Oncol 1991; 18: 18. PubMed
- Gadner H, Grois N, Arico N, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001; 138: 728-34. PubMed
- Honar Cherif, med dr och överläkare, Hematologikliniken, Akademiska sjukhuset, Uppsala
Tidigare sakkunniga
- Bjørn Henning Grønberg, specialist i onkologi, överläkare, St. Olavs Hospital, Trondheim
- Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim